Higher Education and Research Bill (Second sitting)

Matt Warman Excerpts

Committee Debate: 2nd sitting: House of Commons
Tuesday 6th September 2016 Public Bill Committees

[The Chair]

Well, I think we want to hear from someone from an even more humble pay grade. Matt?

[Matt Warman (Boston and Skegness) (Con)]

Q I am not sure how to take that.

As Carol and Valerie will know, part of what the Bill seeks to do is put the Nurse review into effect. Where there is some concern—if there is concern—it is about putting research and innovation together and ensuring that the innovation aspect continues to be complementary but also to work as well as it can. Dr Kingman, can you tell us how you envisage that working in practice and how you will safeguard the innovation aspect in particular?

Dr John Kingman: You are absolutely right about the range of views on this topic, though I think they might be coming together a little bit.

I believe very strongly that we would be better advised to have Innovate UK in the new body. I have been involved in this area over a long period and I think one of the things we have got better at over the years is recognising that the world does not divide starkly between the basic pursuit of pure knowledge and the exciting innovation happening in British companies. Actually, there is an interesting terrain between these two extremes and it is much better filled than it used to be. We are seeing part of that in how Innovate UK has really come on as an organisation and it is doing a lot of interesting work, working with the research councils within that terrain.

I think we would lose something and it would be a step backward if we somehow disconnected Innovate UK. That said, there are very important protections in the Bill that I fully support. It is correct to say Innovate UK has a very different culture and mission and a rather different—for the want of a better phrase—client base than the research councils. I was involved in the creation of the original technology strategy board that preceded Innovate UK. As I said, that organisation has really come on, and my responsibility, if Parliament chooses that it should be, is to nurture that and to build within this mid-terrain as far as we can.

[Matt Warman]

Q Will you give us a sense of what that means in practice in terms of the measures that you approve of in this Bill that you mentioned but were not specific about?

Dr John Kingman: The Bill is very clear that Innovate UK has to focus on the growth of the economy and on business, which obviously involves a distinct set of legal duties from those that apply to the research councils. It is also quite clear that the separate status and standing of Innovate UK as an organisation is permanently protected in the Bill and I welcome that. Frankly, even if these protections were not in the Bill, my approach to the role would certainly be one that—you know, I would like to see Innovate UK come further faster. I will be challenging it to do so in a supportive and constructive way. That simply reflects the approach that I have taken throughout my career with other hats on.

[The Chair]

Okay, we have a long list: Roger and then Valerie.